חזרה לתוצאות החיפוש

A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

ישראלמגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Lung Neoplasm Malignant

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Shaare Zedek Medical Center ( Site 0186), Jerusalem, Israel

    Study coordinator · +97226555999

  • Sheba Medical Center ( Site 0180), Ramat Gan, Israel

    Study coordinator · +97235303030

  • Clermont Oncology Center ( Site 0041), Clermont, Florida, United States

    Study coordinator · 386-538-3169

  • University of Illinois Hospital & Health Sciences System ( Site 0044), Chicago, Illinois, United States

    Study coordinator · 312-996-9272

  • Providence Portland Medical Center ( Site 0043), Portland, Oregon, United States

    Study coordinator · 503-215-1979

  • Providence Oncology and Hematology Care Clinic - Westside ( Site 0059), Portland, Oregon, United States

    Study coordinator · 503-215-1979

  • Hospital São Lucas da PUCRS ( Site 0283), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +555133203000

  • Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0282), Barretos, São Paulo, Brazil

    Study coordinator · +551733216637

  • Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0286), São José do Rio Preto, São Paulo, Brazil

    Study coordinator · +551732015000

  • Hospital Paulistano ( Site 0280), São Paulo, São Paulo, Brazil

    Study coordinator · 55 11 31411083

  • Centro de Estudios Clínicos SAGA-CECSAGA ( Site 0162), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56991612199

  • FALP ( Site 0161), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56229490970

  • Bradfordhill ( Site 0160), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56229490970

  • Guangdong Provincial People s Hospital ( Site 0300), Guangzhou, Guangdong, China

    Study coordinator · 02083525210

  • THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA" ( Site 0204), Athens, Attica, Greece

    Study coordinator · +30210 7763100

  • Alexandra General Hospital of Athens-ONCOLOGY DEPT. ( Site 0205), Athens, Attica, Greece

    Study coordinator · +302132162543

  • Queen Mary Hospital ( Site 0230), Hong Kong, Hong Kong

    Study coordinator · +85222551727

  • Hong Kong United Oncology Centre ( Site 0232), Jordan, Hong Kong

    Study coordinator · +852 5508 7858

  • Prince of Wales Hospital ( Site 0231), Shatin, Hong Kong

    Study coordinator · +852 3505 1202

  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" ( Site 0176), Meldola, Forli-Cesena, Italy

    Study coordinator · 393487469100

  • Severance Hospital, Yonsei University Health System ( Site 0080), Seoul, South Korea

    Study coordinator · +82222280880

  • Institut Català d'Oncologia - L'Hospitalet ( Site 0090), Hospitalet, Barcelona, Spain

    Study coordinator · 0034932607744

  • Hospital Clinic de Barcelona ( Site 0092), Barcelona, Spain

    Study coordinator · 34 932275402

  • Hospital Universitario Virgen Macarena ( Site 0093), Seville, Spain

    Study coordinator · +34 671560092
מובילי המחקר

  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)